Eden Research (LON:EDEN) Trading Down 0.2% – Here’s What Happened

Eden Research plc (LON:EDEN)’s share price dropped 0.2% during trading on Friday . The company traded as low as GBX 3.59 ($0.05) and last traded at GBX 3.59 ($0.05). Approximately 10,000 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 920,772 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 3.3 %

The stock has a fifty day moving average price of GBX 3.87 and a 200 day moving average price of GBX 3.95. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The stock has a market capitalization of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92.

Insider Transactions at Eden Research

In related news, insider Lykele van der Broek purchased 256,000 shares of the business’s stock in a transaction dated Thursday, February 6th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). Also, insider Alexander John Abrey purchased 540,540 shares of the business’s stock in a transaction dated Tuesday, January 28th. The stock was bought at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). Corporate insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.